Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
11/25/2010 | WO2010135568A1 Benzoxazepines as inhibitors of mtor and their use to treat cancer |
11/25/2010 | WO2010135524A1 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases |
11/25/2010 | WO2010134846A1 Substituted 8-sulfonyl-2,3,4,5-tetrahydro-1h-gamma-carbolines, ligands and pharmaceutical composition; method for the production and use of same |
11/25/2010 | WO2010133794A1 Anticancer compound and pharmaceutical composition containing the same |
11/25/2010 | WO2010133318A1 Methods for the identification of phosphatidylinositol kinase interacting molecules and for the purification of phosphatidylinositol kinase proteins |
11/25/2010 | WO2010132951A1 Oligothiophenes and uses thereof in photovoltaic devices |
11/25/2010 | WO2010114928A3 Propane- i-sulfonic acid {3- [5- (4 -chloro-phenyl) -1h-pyrrolo [2, 3-b] pyridine-3-carbonyl] -2, 4-difluoro-pheny l } -amide compositions and uses thereof |
11/25/2010 | WO2010112826A3 Quinoline or naphthyridine herbicides |
11/25/2010 | WO2010106436A3 Novel anti-inflammatory agents |
11/25/2010 | WO2010056585A3 Heteroaryl diamide compounds useful as mmp-13 inhibitors |
11/25/2010 | WO2010003533A3 Pyridopyrimidine compounds as anti-tubercular agents |
11/25/2010 | WO2009142842A9 Novel macrocyclic inhibitors of hepatitis c virus replication |
11/25/2010 | US20100298566 Process for the preparation of paliperidone and its intermediates |
11/25/2010 | US20100298562 Pyridazine and Pyrrole Compounds, Processes For Obtaining Them and Uses |
11/25/2010 | US20100298374 Nitrile derivatives and their pharmaceutical use and compositions |
11/25/2010 | US20100298342 Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's Disease |
11/25/2010 | US20100298339 [1,2,4]Triazolo[1,5-a]Pyridine and [1,2,4]Triazolo[1,5-c]Pyrimidine Compounds and Their Use |
11/25/2010 | US20100298320 Pyrido[2,3-b]pyrazin-8-substituted Compounds and Their Use |
11/25/2010 | US20100298314 Novel jnk inhibitors |
11/25/2010 | US20100298307 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use |
11/25/2010 | US20100298306 (1,4-Diaza-bicyclo[3.2.2]non-6-en-4-yl)-heterocyclyl-methanone Ligands for Nicotinic Acetylcholine Receptors, Useful for the Treatment of Disease |
11/25/2010 | US20100298303 Cgrp receptor antagonists |
11/25/2010 | US20100298288 Cetp inhibitors derived from benzoxazole arylamides |
11/25/2010 | US20100298287 Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them |
11/25/2010 | US20100297128 Gamma secretase modulators |
11/25/2010 | US20100297009 Self-assembled polyhedral multimeric chemical structures |
11/25/2010 | US20100294998 Aromatic imide-based dispersant for carbon nanotubes and carbon nanotube composition comprising the same |
11/25/2010 | CA2763099A1 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases |
11/25/2010 | CA2762233A1 Anticancer compound and pharmaceutical composition containing the same |
11/25/2010 | CA2759939A1 Methods for the identification of phosphatidylinositol kinase interacting molecules and for the purification of phosphatidylinositol kinase proteins |
11/24/2010 | EP2253614A1 Inhibitors of IAP |
11/24/2010 | EP2253328A1 Cycloalkyl inhibitors of potassium channel function |
11/24/2010 | EP2252614A1 Novel 3,8-diaza-bicyclo[3.2.1]octane- and 3,9-diaza-bicyclo[3.3.1]-nonane-3-carboxylic acid ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
11/24/2010 | EP2252613A1 Compounds and compositions as modulators of gpr119 activity |
11/24/2010 | EP2252612A1 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
11/24/2010 | EP2252611A1 (dihydro)pyrrolo[2,1-a]isoquinolines |
11/24/2010 | EP1934216B1 Naphthyridin derivatives |
11/24/2010 | EP1917263B1 Process for the preparation of imidazopyridines |
11/24/2010 | EP1899330B1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect |
11/24/2010 | EP1638970B1 Pyrid (2, 1-a) - isoquinoline derivatives as dpp-iv inhibitors |
11/24/2010 | EP1539739B1 Piperidinyl compounds that selectively bind integrins |
11/24/2010 | EP1497287B1 Quinoline derivatives in combination with 5-FU or CPT-11 for use in the treatment of cancer |
11/24/2010 | EP1280764B1 Inhibitors of histone deacetylase |
11/24/2010 | CN1925859B 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as GABA receptor ligands for the treatment of anxiety, depression and epilepsy |
11/24/2010 | CN1578660B Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
11/24/2010 | CN101896479A Process for the preparation of pyrido [2,1-a] isoquinoline derivatives |
11/24/2010 | CN101891740A Method for extracting laburnine from upper part of thermopsis lanceolate |
11/24/2010 | CN101891739A Pyridino-uracil peptide nucleic acid monomer and intermediate thereof as well as preparation method and application of same |
11/24/2010 | CN101891627A Ruthenium-containing coordination compound and preparation method thereof |
11/24/2010 | CN101890018A Tyrosine protein kinase inhibitor and preparation method thereof |
11/24/2010 | CN101139347B Banisterine derivative compound and uses thereof |
11/23/2010 | US7838681 Synthesis of substituted heterocyclic compounds |
11/23/2010 | US7838674 2-(1-amino-cyclobutylmethyl)-8-(4-methoxy-phenyl)-4,5-dihydro-1 H-1,7,9-triazacyclopenta[a]naph-thalene-3-carboxylic acid lactame; useful especially as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 (MK2 or MAPKAP kinase-2 |
11/23/2010 | US7838533 Azaindole inhibitors of MTP and ApoB |
11/23/2010 | US7838527 Methods of treating cancer and related methods |
11/23/2010 | CA2599860C 1, 2, 4-triazole derivatives and their use as oxytocin antagonists |
11/23/2010 | CA2496295C Novels pyrazole compounds as transforming growth factor (tgf) inhibitors |
11/23/2010 | CA2480776C Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone |
11/23/2010 | CA2440014C Beta-carboline derivatives and its pharmaceutical use against depression and anxiety |
11/18/2010 | WO2010132598A1 Heteroaryl compounds as pikk inhibitors |
11/18/2010 | WO2010132538A1 Fused tricyclic aryl compounds useful for the treatment of viral diseases |
11/18/2010 | WO2010131145A1 Cyclobutenedione derivatives |
11/18/2010 | WO2010130665A1 Azacyclic spiroderivatives as hsl inhibitors |
11/18/2010 | WO2010130424A1 1,2,3-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders |
11/18/2010 | WO2010130423A1 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
11/18/2010 | WO2010130422A1 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
11/18/2010 | WO2010130147A1 Pyronaridine lactate, pharmaceutical composition and use thereof |
11/18/2010 | WO2010130034A1 Inhibitors of human immunodeficiency virus replication |
11/18/2010 | WO2010108074A3 Inhibitors of pi3 kinase |
11/18/2010 | WO2010107791A3 Pyrazinoisoquinoline compounds |
11/18/2010 | WO2010059611A3 Inhibitors of diacylglycerol acyltransferase |
11/18/2010 | US20100292479 Novel compound having affinity for amyloid |
11/18/2010 | US20100292477 Solid forms and process for preparing |
11/18/2010 | US20100292266 Oxazolyl Piperidine Modulators of Fatty Acid Amide Hydrolase |
11/18/2010 | US20100292263 Cgrp receptor antagonists with tertiary amide, sulfonamide, carbamite and urea groups |
11/18/2010 | US20100292262 4 (pyrrolo[2,3-c]pyridine-3-yl)pyrimidin-2-amine derivatives |
11/18/2010 | US20100292254 Fused Pyrimidine Derivatives as Trpv3 Modulators |
11/18/2010 | US20100292250 CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROPHENYL)-1,2,3,4- TETRAHYDROISOQUINOLINE AND USE THEREOF |
11/18/2010 | US20100292243 7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF |
11/18/2010 | US20100292242 Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof |
11/18/2010 | US20100292241 3,5-substituted-1,3-oxazolidin-2-one derivatives |
11/18/2010 | US20100292238 Phenoxymethyl Heterocyclic Compounds |
11/18/2010 | US20100292234 Triazole fused heteroaryl compounds and methods of use thereof |
11/18/2010 | US20100292232 Non-nucleoside reverse transcriptase inhibitors |
11/18/2010 | US20100292231 Indazole Compounds for Treating Inflammatory Disorders, Demyelinating Disorders and Cancers |
11/18/2010 | US20100292225 Aryl pyridine as aldosterone synthase inhibitors |
11/18/2010 | US20100292212 New azacyclic derivatives |
11/18/2010 | US20100292196 Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors |
11/18/2010 | US20100290992 Nanoparticle nucleic acid binding compound conjugates forming i-motifs |
11/18/2010 | CA2762036A1 Inhibitors of human immunodeficiency virus replication |
11/18/2010 | CA2760837A1 7-([1,2,4]triazolo[1,5,-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof |
11/18/2010 | CA2760778A1 Heteroaryl compounds as pikk inhibitors |
11/18/2010 | CA2760741A1 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders |
11/18/2010 | CA2760340A1 Azacyclic spiroderivatives as hsl inhibitors |
11/18/2010 | CA2760259A1 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
11/18/2010 | CA2760205A1 Fused tricyclic aryl compounds useful for the treatment of viral diseases |
11/18/2010 | CA2760084A1 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
11/17/2010 | EP2251341A1 Heterocyclic Janus kinase 3 inhibitors |
11/17/2010 | EP2251340A1 Substituted tetrahydro-1h-pyrazolo[3,4-c] pyridines, compositions containing same and use thereof |
11/17/2010 | EP2251339A2 Compounds |